Krystal Biotech, Inc. (KRYS) Social Stream



Krystal Biotech, Inc. (KRYS): $177.02

1.08 (-0.61%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

B

Add KRYS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#44 of 332

in industry

Featured Post From StockTwits About KRYS

$ARCT Yeah CF drug CTA bumped a bit. OTC got delayed like a month. Typical. Believe this and $KRYS are undervalued plays on CF. Translate Bio’s mRNA lead candidate for CF had less than encouraging to results. Their other next is yet to go into IND enabling studies. Arrowhead had a blow with safety concerns for their drug. Krystal will be “in the lead” with their drug entering Phase 1 this quarter and Arcturus is next, now early 2022. Different approaches. Early, but I have to imagine that Vertex will approach someone early on.

Krystal Bio is one of my favorites, if not my favorite going into Q4, 2 awesome catalysts.
mahngos, published August 11, 2021

What Else are KRYS Traders Talking About?


Other tickers frequently mentioned alongside KRYS is ARCT.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!